Alzheimer disease: quantitative analysis of I-123-iodoamphetamine SPECT brain imaging

• Published in: Radiology Vol. 172; no. 1; p. 183
• Main Authors: Hellman, R S, Tikofsky, R S, Collier, B D, Hoffmann, R G, Palmer, D W, Glatt, S L, Antuono, P G, Isitman, A T, Papke, R A
• Format: Journal Article
• Language: English
• Published: United States 01.07.1989
• Subjects: Adult; Aged; Aged, 80 and over; Alzheimer Disease - diagnostic imaging; Amphetamines; Brain - diagnostic imaging; Female; Humans; Iodine Radioisotopes; Iofetamine; Male; Middle Aged; Tomography, Emission-Computed
• ISSN: 0033-8419
• DOI: 10.1148/radiology.172.1.2787034

To enable a more quantitative diagnosis of senile dementia of the Alzheimer type (SDAT), the authors developed and tested a semiautomated method to define regions of interest (ROIs) to be used in quantitating results from single photon emission computed tomography (SPECT) of regional cerebral blood flow performed with N-isopropyl iodine-123-iodoamphetamine. SPECT/IMP imaging was performed in ten patients with probable SDAT and seven healthy subjects. Multiple ROIs were manually and semiautomatically generated, and uptake was quantitated for each ROI. Mean cortical activity was estimated as the average of the mean activity in 24 semiautomatically generated ROIs; mean cerebellar activity was determined from the mean activity in separate ROIs. A ratio of parietal to cerebellar activity less than 0.60 and a ratio of parietal to mean cortical activity less than 0.90 allowed correct categorization of nine of ten and eight of ten patients, respectively, with SDAT and all control subjects. The degree of diminished mental status observed in patients with SDAT correlated with both global and regional changes in IMP uptake.